SEC Form 4 · accession 0001127602-19-010857
Moderna, Inc. · MRNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lorence H. Kim
Officer — Chief Financial Officer
Period of report
Mar 8, 2019
Accepted (ET)
Mar 11, 2019 · 5:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001682852
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $20.93 | Mar 8, 2019 | A | 211,997 | A | Mar 8, 2020 | Mar 8, 2029 | Common Stock | 211,997 | 211,997 | D |
Explanation of responses
- F125% of this option will vest and become exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter.